Welsis (WLSS) Gross Margin (2023)
Welsis' quarterly Gross Margin came in at 100.0% in Q4 2023.
Welsis has reported Gross Margin for 1 years, with the latest figure at 100.0% in Q4 2023.
- For the quarter ending Q4 2023, Gross Margin changed N/A year-over-year to 100.0%; the trailing twelve-month figure through Sep 2024 stood at 100.0% (changed N/A YoY), and the FY2024 full-year result was 100.0%, up 4854.0% from the prior year.
- Gross Margin for Q4 2023 stood at 100.0%.
- The five-year high for Gross Margin was 100.0% in Q4 2023, with the low at 100.0% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 74.46% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 13.34% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 72.27% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 84.60% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 86.65% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 85.40% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 70.39% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 98.65% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 45.30% |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100.00% |